4-[(4-Methylpiperazin-1-yl)methyl]benzoic acid dihydrochloride CAS 106261-49-8 Imatinib Mesylate Intermediate High Purity
Ukunikezwa Kwezohwebo I-Imatinib Mesylate kanye Nezixhumanisi Ezihlobene:
I-Imatinib Mesylate CAS: 220127-57-1
N-(2-Methyl-5-nitrophenyl)-4-(pyridin-3-yl)pyrimidin-2-amine CAS: 152460-09-8
N-(5-Amino-2-methylphenyl)-4-(3-pyridyl)-2-pyrimidinea CAS: 152460-10-1
4--[(4-Methylpiperazin-1-yl)methyl]benzoic acid dihydrochloride CAS: 106261-49-8
Igama Lekhemikhali | 4--[(4-Methylpiperazin-1-yl)methyl]benzoic acid dihydrochloride |
Omqondofana | I-Imatinib Mesylate Intermediate |
Inombolo ye-CAS | 106261-49-8 |
Inombolo yeCAT | I-RF-PI229 |
Isimo Sesitoko | Esitokweni, Isikali Sokukhiqiza Sifinyelela Kumathani |
I-Molecular Formula | I-C13H20Cl2N2O2 |
Isisindo samangqamuzana | 307.22 |
I-Melting Point | 305.0~307.0℃ |
Ukuncibilika | Incibilika Emanzini |
Ibhrendi | I-Ruifu Chemical |
Into | Imininingwane |
Ukubukeka | Impushana Emhlophe Kuya Kucishe Emhlophe kuya kuCrystal |
Ukuhlanzeka / Indlela Yokuhlaziya | ≥98.0% (HPLC) |
Ukulahlekelwa Ekumisweni | ≤0.50% |
Izinsalela ekushiseni | ≤0.50% |
Ukungcola Okuphelele | ≤2.0% |
Ukungcola Okukodwa Okukhulu | ≤1.0% |
Izinga Lokuhlola | I-Enterprise Standard |
Ukusetshenziswa | I-Pharmaceutical Intermediate ye-Imatinib Mesylate (CAS: 220127-57-1) |
Iphakheji: Ibhodlela, isikhwama se-Aluminium foil, isigubhu seCardboard, 25kg/Drum, noma ngokwezidingo zekhasimende.
Isimo Sesitoreji:Gcina ezitsheni ezivaliwe endaweni epholile neyomile;Vikela ekukhanyeni, umswakama kanye nezinambuzane.
I-Shanghai Ruifu Chemical Co., Ltd. ingumkhiqizi oholayo nomnikezeli we-4--[(4-Methylpiperazin-1-yl)methyl]benzoic acid dihydrochloride (CAS: 106261-49-8) enekhwalithi ephezulu.Itiyindawo ephakathi ngokuvamile ekuhlanganisweni kwe-Imatinib Mesylate (CAS: 220127-57-1).I-Imatinib Mesylate iyi-tyrosine kinase inhibitor, ecaciselwe kakhulu i-BCR-ABL, isidakamizwa somlomo sokwelashwa kweziguli ezikhulile ezine-Philadelphia chromosome positive chronic myeloid leukemia (CML) esigabeni esibucayi kanye nezinhlobo ezithile ze-acute lymphoblastic leukemia (ALL), isheshisiwe. isigaba kanye nesigaba esingapheli ngemva kokuhluleka kokwelashwa kwe-interferon.